BackG1 Therapeutics Overview

G1 Therapeutics Other Income Expense Net

Other Income/Expense Net for GTHX.

Quarterly Other Income/Expense

-$1.93M
↓ 439.89% YoY

As of Jun 30, 2024

Annual Other Income/Expense (TTM)

-$5.08M
↑ 16.21% YoY

Trailing 12 months ending Jun 30, 2024

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin